Financial statements Alvogen Pharma
Cash flow statement of Alvogen Pharma
Share capital:
Share capital:
5 000 PLN
Company deleted from KRS: 2022-03-09
Cash inflows of ALVOGEN PHARMA
|
Year
|
2018
|
2019
|
2020
|
|---|---|---|---|
| Net cash from operating expenses | - | 1 461 503,28 | 2 653 406,99 |
| Net cash flow from investing activities | - | -3 010 617,29 | 372 729,22 |
| Net cash flow from financial activities | - | 2 700 248,80 | 7 383 066,37 |
| Total net cash flow | - | 1 151 134,79 | 10 409 202,58 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.